Last reviewed · How we verify
B&L ReNu MultiPlus™
At a glance
| Generic name | B&L ReNu MultiPlus™ |
|---|---|
| Sponsor | University of Waterloo |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- B&L ReNu MultiPlus™ CI brief — competitive landscape report
- B&L ReNu MultiPlus™ updates RSS · CI watch RSS
- University of Waterloo portfolio CI